Taho Pharmaceuticals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '17 Dec 31, 2017
Cash & Equivalents	147.19	339.98	245.87	151.71	74.3	83.99
Short-Term Investments	200	50	250	78.07	32	44.64
Cash & Short-Term Investments	347.19	389.98	495.87	229.77	106.3	128.63
Cash Growth	-29.98%	-21.36%	115.81%	116.16%	-17.36%	-42.63%
Accounts Receivable	0.01	0.16	-	-	-	1.38
Other Receivables	0.84	0.65	0.87	0.29	0.03	0.13
Receivables	0.85	0.8	0.87	0.29	0.03	1.51
Inventory	-	-	-	-	-	3.95
Prepaid Expenses	2.81	2.85	2.18	3.24	4.96	8.94
Other Current Assets	-	-	-	-	-	1.35
Total Current Assets	350.85	393.62	498.92	233.31	111.29	144.38
Property, Plant & Equipment	24.01	22.45	24.86	23.55	4.33	30.26
Long-Term Investments	8	7.86	8.01	-	-	-
Other Intangible Assets	0.69	0.74	-	-	-	17.32
Other Long-Term Assets	29.45	30.92	28.91	26.34	22.93	7.48
Total Assets	412.99	455.6	560.7	283.2	138.54	199.44
Accounts Payable	-	-	-	-	-	12.03
Accrued Expenses	11.6	17.73	24.74	21.53	10.5	3.93
Short-Term Debt	-	-	-	-	-	0.91
Current Portion of Leases	5.6	5.55	5.34	4.97	-	-
Current Unearned Revenue	-	-	0.71	-	0.19	-
Other Current Liabilities	2.42	2.76	2.28	33.2	35.8	8.47
Total Current Liabilities	19.62	26.04	33.06	59.7	46.49	25.35
Long-Term Leases	4.34	5.77	11.31	16.65	-	-
Long-Term Deferred Tax Liabilities	-	-	-	-	-	0.64
Other Long-Term Liabilities	0.08	0.09	0.12	0.15	-	-
Total Liabilities	24.05	31.9	44.5	76.5	46.49	25.99
Common Stock	523.71	523.56	512.16	423.07	372.97	523.12
Additional Paid-In Capital	122.58	114.69	388.42	256.19	70.96	1.88
Retained Earnings	-257.34	-214.4	-384.38	-472.57	-351.89	-354.68
Comprehensive Income & Other	-0.01	-0.15	-	-	-	3.13
Shareholders' Equity	388.94	423.7	516.2	206.69	92.05	173.45
Total Liabilities & Equity	412.99	455.6	560.7	283.2	138.54	199.44
Total Debt	9.95	11.31	16.65	21.62	-	0.91
Net Cash (Debt)	337.25	378.66	479.22	208.15	106.3	127.72
Net Cash Growth	-29.63%	-20.98%	130.22%	95.82%	-16.77%	-42.91%
Net Cash Per Share	6.52	7.36	10.56	5.37	2.96	2.44
Filing Date Shares Outstanding	52.37	52.36	51.22	51.22	35.96	52.31
Total Common Shares Outstanding	52.37	52.36	51.22	51.22	35.96	52.31
Working Capital	331.23	367.58	465.86	173.61	64.79	119.03
Book Value Per Share	7.43	8.09	10.08	4.04	2.56	3.32
Tangible Book Value	388.25	422.96	516.2	206.69	92.05	156.13
Tangible Book Value Per Share	7.41	8.08	10.08	4.04	2.56	2.98
Machinery	65.22	62.3	59.45	52.84	54.42	53.06
Leasehold Improvements	18.06	17.25	14.03	13.81	13.75	10.72